Investor Shelf

Funder directory / United Kingdom / Venture capital firms

Syncona

Venture capitalLondon, United Kingdomsynconaltd.comVerified 10 Nov 2026

Syncona is a life science healthcare investor that funds, builds, and manages companies aimed at delivering transformational treatments to patients. It invests in life science businesses across various stages of development, from pre-clinical research to commercial stage.

StagesSeries A · Growth
Deals recorded22 since 2022

What they invest in

  • Our Investment Manager has created a portfolio of life science companies and is investing in and managing these companies to deliver key value inflection points, which have the potential to deliver significant NAV growth through M&A and liquidity events. source
  • A portfolio of life science companies diversified across different stages of the development cycle and a range of therapeutic areas. source
  • We have a portfolio of leading life science companies that are seeking to deliver transformational treatments to patients. source

All investments and operations

22 operations
CompanyRoundAmountDateCo-investorsSource
Beacon TherapeuticsSeries A–2023–Portfolio page
Kesmalea TherapeuticsSeries A–2022–Portfolio page
Mosaic TherapeuticsSeries A–2022–Portfolio page
14MG––––Portfolio page
Anaveon––––Portfolio page
Autolus Therapeutics––––Portfolio page
Azeria Therapeutics––––Portfolio page
Blue Earth––––Portfolio page
Clade Therapeutics––––Portfolio page
Forcefield Therapeutics––––Portfolio page
Show all 22 operations
Gyroscope Therapeutics––––Portfolio page
iOnctura––––Portfolio page
Neogene Therapeutics––––Portfolio page
Nightstar––––Portfolio page
OMass Therapeutics––––Portfolio page
Purespring Therapeutics––––Portfolio page
Quell Therapeutics––––Portfolio page
Re-Aim Therapeutics––––Portfolio page
Resolution Therapeutics––––Portfolio page
Slingshot Therapeutics––––Portfolio page
Spur Therapeutics––––Portfolio page
Yellowstone Biosciences––––Portfolio page

Similar funders